Claes Öhlén
Karolinska Institutet
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Claes Öhlén.
Immunology Today | 1992
Lorenzo Moretta; Ermanno Ciccone; Alessandro Moretta; Petter Höglund; Claes Öhlén; Klas Kärre
The issue of antigen recognition by NK cells is complex, fascinating and, as yet, unresolved. This article reviews recent research on the repertoire of human NK cell clones for the recognition of different allogeneic cells, and summarizes the studies, most of which have been performed in mice, that implicate the MHC in NK cell recognition. It goes on to provide a common conceptual framework within which these different systems may be understood.
Cold Spring Harbor Symposia on Quantitative Biology | 1989
Alain Townsend; Claes Öhlén; L. Foster; Judy Bastin; Hans-Gustaf Ljunggren; Klas Kärre
Association of the Db heavy chain with beta 2-microglobulin and expression of Db and Kb at the surface of the cell are induced by specific peptides in the mutant RMA-S. Association of antigenic peptides with the binding site of class I molecules may be required for correct folding of the heavy chain, association with beta 2-microglobulin, and transport of the antigen-MHC complex to the cell surface.
Cellular Immunology | 1989
Toshiki Yamasaki; Hans-Gustaf Ljunggren; Claes Öhlén; George Klein; Klas Kärre
The relationship between MHC class I (H-2) expression and tumorigenicity was investigated after intracerebral inoculation of the murine lymphoma YAC-1 and its H-2 negative variant, A.H-2-. YAC-1 was less tumorigenic than A.H-2- in normal as well as NK-depleted syngeneic A/Sn mice. However, in T-cell-depleted syngeneic mice YAC-1 was as tumorigenic as A.H-2-. Following intracerebral growth, the H-2 expression of YAC-1 was markedly enhanced in a similar fashion as after intraperitoneal passage. The A.H-2- variant remained H-2 negative after intracranial passage. The H-2 negative variant cells were not rejected from the brain even when intermixed with wild-type YAC-1 cells prior to intracerebral inoculation, excluding an innocent bystander effect. In vitro, the intracerebrally passaged YAC-1 line showed enhanced sensitivity to lysis by H-2 Kk Dd (H-2a) specific CTLs but decreased sensitivity to NK cells. The A.H-2- line was unchanged. Our data suggest that the lack of H-2 molecules may facilitate the growth of antigenic tumor cells in the brain due to escape from T-cell-mediated immunosurveillance. Our data also suggest, in line with other recent findings, that intracerebrally growing tumor cells are sheltered from NK cell-mediated rejection.
Nature | 1989
Alain Townsend; Claes Öhlén; Judy Bastin; Hans-Gustaf Ljunggren; L. Foster; Klas Kärre
Nature | 1990
Hans-Gustaf Ljunggren; Nico J. Stam; Claes Öhlén; Jacques Neefjes; Petter Höglund; Marie-Therese Heemels; Judy Bastin; Ton N. M. Schumacher; Alain Townsend; Klas Kärre; Hidde L. Ploegh
Proceedings of the National Academy of Sciences of the United States of America | 1991
Petter Höglund; Claes Öhlén; Ennio Carbone; Lars Franksson; Hans-Gustaf Ljunggren; A Latour; Beverly H. Koller; Klas Kärre
European Journal of Immunology | 1991
Fumie Aosai; Claes Öhlén; Hans-Gustaf Ljunggren; Petter Höglund; Lars Franksson; Hidde Ploegh; Alain Townsend; Kias Kärre; Hans J. Stauss
Proceedings of the National Academy of Sciences of the United States of America | 1992
Rickard Glas; Lars Franksson; Claes Öhlén; Petter Höglund; Beverly H. Koller; Hans-Gustaf Ljunggren; Klas Kärre
International Journal of Cancer | 1989
Ignacio Algarra; Claes Öhlén; Matias Perez; Hans-Gustaf Ljunggren; George Klein; Federico Garrido; Klas Kärre
European Journal of Immunology | 1995
Claes Öhlén; Petter Höglund; Charles L. Sentman; Ennio Carbone; Hans-Gustaf Ljunggren; Beverly H. Koller; Klas Kärre